Tag: Pharmaceutical Distribution

Collaboration of Latvian and Chinese Companies

Chemspace and LabNetwork, a WuXi AppTec company, both online marketplaces for chemical compounds used in drug discovery, announced they have entered into a collaboration agreement. Under the agreement...

First Company for medical Cannabis pursue licences around Europe

The Frankfurt-based pharmaceutical company Farmako is a research-based pharmaceutical company that distributes medical cannabis. The company is active in all European markets that have created a legal...

Neovii & Mundipharma entered into licensing agreement

drug-development
Neovii pharmaceuticals AG of Rapperswil, Switzerland and Mundipharma have entered into an agreement giving Mundipharma the rights to develop and distribute its polyclonal antibody immunosuppressant Gr...

Fujifilm signed a distribution agreement with R-Pharm

fujifilm
FUJIFILM Corporation signed a distribution agreement with a major Russian pharmaceutical company JSC “R-Pharm” for the distribution of Fujifilm's medical devices in Russia.

EAEU rules of Good Distribution Practice became effective on April 27

drugs
EAEU rules of Good Distribution Practice (GDP) were adopted by the Decision of the Council of the Eurasian Economic Commission (EEC) No. 80 of November 3, 2016, while their entry into force was postponed for 18 months.

Ibnsina Pharma will distribute Novo Nordisk products in Egypt

ibnsina pharma egypt
Ibnsina Pharma, Egypt’s fastest-growing and second-largest pharmaceutical distributor, has signed two contracts with Novo Nordiskto distribute over 20 stock-keeping units of its products in Egypt.

Tilray set up a strategic alliance with a leading Canadian pharma company

medicinal cannabis
Tilray, a licensed producer of medical cannabis, signed a binding letter of intent to be the collaborator of a major pharma company to accelerate innovation and increase availability of high quality medical cannabis products.

Blockchain technology has a special potential to confront counterfeit drugs

blockchain
DHL released a report in cooperation with Accenture on blockchain technology’s potential. The report includes findings on a working prototype which tracks pharmaceuticals from the point of origin to the consumer.

R-Pharm Kazakhstan receives a GDP compliance certificate

manufacturing
In February 2018, the division of R-Pharm Group in Kazakhstan received a certificate of compliance with the Good Distribution Practice (GDP) from the Ministry of Health of the Republic of Kazakhstan. ...

Almac Group opens a custom built cold store facility in Northern Ireland

almac
Almac Group announced the completion of a $27.5 million investment in its cold chain management capabilities with the opening of a custom built cold store facility in Northern Ireland.

Mundipharma will distribute Grünenthal’s analgesic in China

tramal
Grünenthal and Mundipharma announced today that they have entered into a License and Distribution Agreement. Under its terms, Mundipharma will market and distribute Grünenthal’s Tramal® in China

Cardiome Pharma brings Aggrastat to Russian market

cardiology
Cardiome Pharma announced that its affiliate Correvio has entered into an exclusive license and distribution agreement with ZAO Firma Euroservice

French and Turkish pharmaceutical distributors formed a strategic alliance

deal
Safic-Alcan, a French independent distributor, announces that it has established a strategic alliance with Marmara Ecza, a Turkish pharma supplier

Russian pharmaceutical distributors may expect a restructuring

drugs russia
Due to the establishment of common drug market of EAEU, the Russian government is preparing the amendments to the legislation regarding the release of drugs into civil circulation

Oasmia makes new distribution and marketing agreement concerning Russia

pharma-distribution
Oasmia Pharmaceutical, has entered into a new exclusive marketing and distributions agreement with Hetero Group with the goal of driving revenue in Russia and other CIS markets

Enzymatica got the largest order from STADA

Enzymatica, a Swedish life science company, has received its largest order to date for a total of about SEK 12 million